| |
|
|
|
|
|
|
|||
|
Blood, 1 September 2007, Vol. 110, No. 5, pp. 1530-1539. Prepublished online as a Blood First Edition Paper on May 10, 2007; DOI 10.1182/blood-2006-10-048173.
IMMUNOBIOLOGY The unexpected effect of cyclosporin A on CD56+CD16– and CD56+CD16+ natural killer cell subpopulationsDepartments of1 Pediatrics and 2 Medicine, Division of Blood and Marrow Transplantation; 3 Biostatistics Shared Resource, Cancer Center, University of Minnesota, Minneapolis; 4 Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA
Cyclosporin A (CSA) is commonly used to prevent graft-versus-host disease. The influence of CSA on T-cell function has been extensively investigated; however, the effect of CSA on natural killer (NK) cells is less understood. NK cells were cultured with IL-2 and IL-15 with and without CSA for 1 week. Compared with controls, CSA-treated cultures showed fewer CD56+CD16+KIR+ NK cells and a reciprocal increase in CD56+CD16–KIR– cells. These changes were due mainly to a reduced proliferation of the CD56dim NK-cell subpopulation and a relative resistance of CD56bright NK cells to CSA. Following coculture with K562 targets, CSA-exposed NK cells differed from controls and lacked Ca2+ oscillations, nuclear factor of activated T cells (NFAT) dephosphorylation, and NFAT nuclear translocation. NK cells cultured in CSA retained cytotoxicity against K562, Raji, and KIR ligand-expressing lymphoblastoid cells. NK cells cultured in CSA showed increases in NKp30 and reductions in NKp44 and NKG2D. Following IL-12 and IL-18 stimulation, CSA-treated NK cells showed more IFN-
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||